Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Thursday, April 30, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study
Life Sciences Times
-
April 30, 2026
Pharma
Newron Reports FDA Hold on New Enrollment at U.S. Sites in Schizophrenia Study
Life Sciences Times
-
April 30, 2026
Pharma
Verastem Oncology Launches Campaign for KRAS-Mutated Recurrent Ovarian Cancer Treatment
Life Sciences Times
-
April 30, 2026
Pharma
Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal
Life Sciences Times
-
April 29, 2026
Pharma
FDA Accepts New Drug Application for Zipalertinib in EGFR-Mutated Lung Cancer
Life Sciences Times
-
April 28, 2026
Pharma
Pangea Pharmaceuticals Launches First FDA-Approved Amlodipine Powder for Oral Solution in U.S.
Life Sciences Times
-
April 15, 2026
0
Pharma
LYBALVI Shows Sustained Improvement in Negative Symptoms of Schizophrenia in 56-Week Analysis
Life Sciences Times
-
April 14, 2026
0
Pharma
Enanta Doses First Participant in Phase 1 Trial of Oral Urticaria Drug
Life Sciences Times
-
April 13, 2026
0
Pharma
GoodRx Expands Access to New Lilly Weight-Loss Drugs With Discounted Self-Pay Pricing
Life Sciences Times
-
April 9, 2026
0
Pharma
AstraZeneca Combo Therapy Shows Improved Progression-Free Survival in Early Liver Cancer Trial
Life Sciences Times
-
April 2, 2026
0
Pharma
PharmaEssentia Signs Investment Agreement for New Manufacturing Facility in Puerto Rico
Life Sciences Times
-
April 2, 2026
0
Pharma
FDA Expands Use of Vertex Cystic Fibrosis Drugs, Broadening Access to Treatment
Life Sciences Times
-
April 1, 2026
0
Pharma
Scholar Rock Resubmits FDA Application for Apitegromab to Treat Spinal Muscular Atrophy
Life Sciences Times
-
March 31, 2026
0
Pharma
Takeda Reports Strong Phase 3 Results for Oral Psoriasis Drug Zasocitinib
Life Sciences Times
-
March 30, 2026
0
Pharma
Prilenia, Ferrer Enroll First Patient in Phase 3 ALS Drug Trial
Life Sciences Times
-
March 30, 2026
0
Pharma
FDA clears STAR-001 pediatric brain cancer trial targeting aggressive CNS tumors
Life Sciences Times
-
March 27, 2026
0
Pharma
Tozorakimab cuts COPD flare-ups in late-stage trials, marking potential breakthrough
Life Sciences Times
-
March 27, 2026
0
1
2
3
...
91
Page 2 of 91
Most Read
Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study
April 30, 2026
Johnson & Johnson Names Ryan Koors Vice President of Investor Relations
April 30, 2026
Moleculent Raises $20 Million to Expand Functional Profiling Platform
April 30, 2026
Komodo Health Names Paul Thomas Chief Financial Officer
April 30, 2026